| Contact |
General |
Specializations in Countries |
Contribution to the Global Plan |
Declaration |
View this partner's profile
Organization Contact Information |
| Name: |
Afghan Community Research & Empowerment Organization for Development (ACREOD) |
| Street 1: |
House # 2, Street # 2, Road # 2, |
| Street 2: |
Kart-e- Mamorin |
| City: |
Kabul City |
| Province: |
Kabul |
| Post Code: |
0093 |
| Country: |
Afghanistan |
| Phone: |
+93 700625544 |
| Email: |
acreod@gmail.com |
| Web Site: |
|
Focal Point Contact Information |
| Salutation: |
Dr |
| First Name: |
Akmal |
| Last Name: |
Nasrat |
| Title: |
M&E and Research Coordinator |
| Email: |
acreod.anasrat@gmail.com |
| Phone: |
+93 700625544 |
|
Alternate Focal Point Contact Information |
| Salutation: |
Dr. |
| First Name: |
Ataulhaq |
| Last Name: |
Sanaie |
| Title: |
Executive Director |
| Email: |
sanaie.as@gmail.com |
| Phone: |
+93707745090 |
|
General Information |
| Organization Type - Primary: |
Non-Governmental Organization |
| Organization Type - Secondary: |
Other Non-Governmental Organization (NGO) |
| Is your organization legally registered in your country: |
Yes |
| Organization Reach: |
National |
| Organization Description: |
Afghan Community Research & Empowerment Organization for Development (ACREOD) is a non-governmental, non-political and not for profit Afghan organization which is established in 2010 by experienced Afghan team in developmental projects. ACREOD’s vision is “Sustainable Development and Civil Rights available to all Afghans” and mission is “A dedicated firm to operate evidence based interventions for stable improvement in life of Afghan communities particularly the women, the children, tribal minorities, nomads and the most vulnerable”. The team’s long experiences and understandings in TB control management attracted National TB control program (NTP) and Anti TB Association/Afghanistan program (ATA/AP) to work jointly and applied for TB REACH Grants where the application succeeded. In addition to advisory role, ACREOD directly implements the project in Paktia and Kandahar Provinces. Since Tuberculosis constitutes the major and premier health issue in Afghanistan and ACREOD’s technical team has had long lasting experience in TB control, ACREOD remains pledged to eradicate the preventable and curable deadly disease along with the valuable cooperation from international anti-tuberculosis societies. As ACREOD has professional TB team, ACREOD’s contributions will strengthen TB control activities in the country. Currently, as a partner organization with NTP & ATA-AP, ACREOD is implementing TB REACH project in two provinces of the country among IDPs/Returnees, prisoners and Household Contacts whom have been deprived from basic TB services and among adult attendance of health facilities. ACREOD is looking for donors' support to further assist NTP in implementation of National TB Strategic Plan. ACREOD has knocked the doors of Provincial Reconstruction Teams (PRTs) and embassies to draw further financial support for TB control in Afghanistan, but has not succeeded so far. |
| |
| Total number of staff in your organization: |
26 - 50 |
| Number of full-time staff who are directly involved with TB: |
11 - 25 |
| Number of part-time staff who are directly involved with TB: |
0 |
| Number of volunteers who are directly involved with TB: |
1 - 5 |
| |
| What is your organization's annual budget (USD) dedicated to TB? |
$100,001-$500,000 |
| How did you hear about the Stop TB Partnership: |
Stop TB communications |
| Why do you wish join the Stop TB Partnership: |
Network with other partners |
| |
| Are you a member of a Stop TB national partnership: |
Afghanistan |
| Are you in contact with your national TB programme: |
Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: |
| Since ACREOD feels the essentials of coordination with NTP, ACREOD’s all activities are completely in line with National TB strategic plan of Afghanistan because ACREOD is keen to see the plan be administered and the goals be achieved. In addition, at provincial level, ACREOD is a member of TB Taskforce Committee where ACREOD well coordinates its activities with NTP’s provincial teams and other stakeholders. |
| |
Geographical Reach |
| Which country is your headquarters located in: |
Afghanistan |
| Which WHO region is the main focus of your work: |
Eastern Mediterranean |
Which countries do you do operate in: (This includes countries you are conducting activities in) |
Afghanistan |
Specializations |
Advocacy, communication and social mobilization Research and Development TB Healthcare Services Technical Assistance |
Specializations in Countries |
| Advocacy, communication and social mobilization |
Afghanistan |
| Research and Development |
Afghanistan |
| TB Healthcare Services |
Afghanistan |
| Technical Assistance |
Afghanistan |
Contribution |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: |
DOTS Expansion and Enhancement: Since Afghanistan is among the 22 highest TB burden countries and the majority of new detected TB cases are drug susceptible, ACREOD knows the importance of DOTS expansion in the country if Afghanistan is guided towards the set global targets. ACREOD supports DOTS five components and DOTS propagation in the community which constitutes the essential element in DOTS implementation as part of ACSM activities. Since TB services with its effective treatments are free of charge, the organization uses the anthem and propagates it among the community that only effective treatment and controlled management will avoid both TB and its complications. ACREOD is implementing the project, titled, “increase case detection through innovative approaches” among IDPs/Returnees, prisoners, Household Contacts and health facilities’ attendance who have received the least attentions in terms of TB control services. The project has incorporated ASCM activities (DOTS implementation) within its framework because it was highly sensible among the target groups because they lack the essential information related TB and its management. These health messages were delivered through project employed health educators. The consequences of incorporating such ACSM activities in the form of DOTS expansion within the project are highly perceivable since the keen interest of TB patients has increased and they cooperate by themselves in taking their treatment which could finally end in approaching the global plan for 2015.
Drug-Resistant TB: Among all the communities emerging of Drug Resistant TB will not be far beyond thinking because anywhere TB mismanagement will lead to drug resistant TB. Afghanistan also accounts for an unknown number of drug resistant TB who lives in the community and endangers others’ lives. As globally, one of the most important constraints to rapid expansion of diagnosis and treatment for MDR-T is laboratory capacity. Therefore, it would be a dream if we find all the MDR-T in Afghan communities with their limited laboratory facilities. Besides, management of MDR-T is very costly which is outside of the affording of health authorities. Since addressing the abovementioned constraints needs high levels of coordination and cooperation, ACREOD, as an Afghan national NGO, will only contribute to reduce the forthcoming numbers of MDR-T through its proper community awareness about mismanagement of TB, stopping TB treatment and drug resistant TB and its complications more importantly death . ACREOD supports international collaboration in identifying, diagnosing and effectively treating MDR-T through strengthening basic TB control, development of laboratory capacity for diagnosis, establishment of comprehensive patient management and care programs, effective collaboration with HIV programs, strengthening of health information and surveillance systems and acceleration of research and development related to new tools for prevention, diagnosis and treatment as all the mentioned efforts have been defined as effective tools to reach the global plan for 2015. Finally, MDR-T management and reduction need specific considerations by both national and international communities.
TB-HIV: Since TB/HIV is a nowadays deep thoughtful issue, ACREOD based on its technical merit and proficiency has trained and established specialists in the relevant subject, therefore, ACREOD is ready to offer its manpower in case funding is available to work in coordination with donor agencies and control the two joint deadly contagious diseases.
Operational Research: Since the health system differs across the countries, a standard as research must be set so that the proposed interventions must meet health system standards and are implemented smoothly in country level conditions. ACREOD is very technical in researches because research is the cross-cutting expertise of this team and ACREOD believes that proper program-based operational researches are very necessary if optimizing TB control and determining the best ways of implementing and monitoring interventions are planned because operational research will result in a productive policy making, better design and implementation of health system components and more effective ways of service delivery. ACREOD based on its proficiency prefers to strengthen operational research within its project implementation if proper funding is available because ACREOD considers the necessity of applying established and country wide accepted interventions. During its project implementation, ACREOD performs some activities as part of research as: analyses the extent and nature of ongoing health services along with their problems and assess the efficiency and cost effectiveness of new innovative approaches which ACREOD mainly deals with during every project implementation. Therefore, ACREOD strongly supports operational researches projects to address local problems and recommend appropriate solutions, involving partners at all steps. |
Declaration |
Declaration of interests:
No conflicts of interest were delacred.
|
| Application date: |
December 7, 2010 |
| Last updated: |
February 4, 2013 |
|